From the Division of Ophthalmology and Optometry, Department of Ophthalmology, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland (Kaluzny, Piotrowiak-Słupska, Kaszuba-Modrzejewska, Rzeszewska-Zamiara, Stachura); Oftalmika Eye Hospital, Bydgoszcz, Poland (Kaluzny, Piotrowiak-Słupska); SCHWIND eye-tech-solutions, Kleinostheim, Germany (Verma, Arba-Mosquera).
J Cataract Refract Surg. 2021 Apr 1;47(4):450-458. doi: 10.1097/j.jcrs.0000000000000476.
To evaluate refractive and visual outcomes of single-step transepithelial photorefractive keratectomy (transPRK) in the treatment of mixed astigmatism with the use of an aberration-neutral profile and large ablation zone.
Nicolaus Copernicus University and Oftalmika Eye Hospital, Bydgoszcz, Poland.
Retrospective, observational case series.
This study included patients who underwent transPRK to correct mixed astigmatism and completed the 3-year follow-up. Procedures were performed with an Amaris 750S excimer laser using an aberration-neutral profile and optical zone of 7.2 mm or more.
A total 48 eyes of 39 patients were included. Preoperatively, mean spherical manifest refraction was +1.37 ± 0.98 diopter (D) (0.25 to 4.00 D), and astigmatism was -4.00 ± 0.76 D (-2.25 to -6.00 D). Three years postsurgery, it was -0.17 ± 0.26 D and -0.41 ± 0.44 D, respectively. Attempted spherical equivalent correction within ±0.50 D was achieved in 45 eyes (94%) and cylindrical correction in 34 (71%). Preoperative corrected distance visual acuity (CDVA) was 20/20 or better in 38 eyes (79%), and postoperative uncorrected was 20/20 or better in 29 eyes (60.0%). No eye had lost 2 or more Snellen lines of CDVA, whereas 3 eyes (6%) gained 2 or more lines. In 4 eyes (8%), haze of low intensity was observed at the periphery, with scores between 0.5 and 1.0, and only 1 eye getting a score of 2 in 0- to 4-degree scale.
Mixed astigmatism correction with large-ablation-zone transPRK provided good results for efficacy, safety, predictability, and visual outcomes in a 3-year follow-up.
评估使用具有低阶像差中和特性和大光区的一步式经上皮准分子激光角膜切削术(transPRK)治疗混合性散光的屈光和视觉效果。
波兰比得哥什哥白尼大学和 Oftalmika 眼科医院。
回顾性、观察性病例系列。
这项研究纳入了接受 transPRK 治疗混合性散光并完成 3 年随访的患者。手术使用阿玛仕 750S 准分子激光系统进行,采用低阶像差中和特性和 7.2mm 或更大的光学区。
共纳入 39 名患者的 48 只眼。术前平均球镜等效球镜屈光度(SE)为+1.37±0.98 屈光度(D)(0.25 至 4.00 D),散光为-4.00±0.76 D(-2.25 至-6.00 D)。术后 3 年时,SE 为-0.17±0.26 D,散光为-0.41±0.44 D。45 只眼(94%)达到±0.50 D 以内的 SE 目标矫正,34 只眼(71%)达到柱镜目标矫正。术前最佳矫正远视力(BCVA)为 20/20 或更好的有 38 只眼(79%),术后未矫正 BCVA 为 20/20 或更好的有 29 只眼(60.0%)。无 1 只眼丧失 2 行或更多的 BCVA,而有 3 只眼(6%)提高了 2 行或更多。在 4 只眼(8%)中,观察到低强度周边混浊,分数为 0.5 至 1.0,只有 1 只眼在 0 至 4 度量表上的分数为 2。
在 3 年随访中,大光区 transPRK 治疗混合性散光在疗效、安全性、可预测性和视觉效果方面提供了良好的结果。